Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Coagulation | 5 | 2024 | 29 | 1.680 |
Why?
|
| Anticoagulants | 5 | 2024 | 121 | 1.280 |
Why?
|
| Factor XIIa | 3 | 2024 | 3 | 1.180 |
Why?
|
| Factor XIa | 3 | 2022 | 4 | 1.090 |
Why?
|
| Thrombosis | 2 | 2022 | 81 | 0.760 |
Why?
|
| Pentamidine | 2 | 2019 | 9 | 0.740 |
Why?
|
| Fibrinolysis | 1 | 2019 | 2 | 0.620 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2019 | 44 | 0.600 |
Why?
|
| Lipid Bilayers | 3 | 2007 | 56 | 0.550 |
Why?
|
| Thermodynamics | 4 | 2010 | 226 | 0.520 |
Why?
|
| Membrane Proteins | 3 | 2014 | 548 | 0.470 |
Why?
|
| Models, Molecular | 10 | 2024 | 875 | 0.460 |
Why?
|
| Antineoplastic Agents | 5 | 2024 | 979 | 0.460 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 61 | 0.440 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 159 | 0.360 |
Why?
|
| Prothrombin Time | 2 | 2023 | 8 | 0.360 |
Why?
|
| Biomimetic Materials | 1 | 2007 | 24 | 0.270 |
Why?
|
| Catalytic Domain | 3 | 2024 | 118 | 0.270 |
Why?
|
| Mutation | 3 | 2024 | 1169 | 0.260 |
Why?
|
| Alamethicin | 1 | 2006 | 8 | 0.250 |
Why?
|
| Membrane Lipids | 1 | 2006 | 29 | 0.250 |
Why?
|
| Allosteric Site | 2 | 2022 | 12 | 0.230 |
Why?
|
| Amides | 1 | 2005 | 72 | 0.220 |
Why?
|
| Neoplasms | 1 | 2015 | 1341 | 0.210 |
Why?
|
| Animals | 14 | 2024 | 16695 | 0.210 |
Why?
|
| Humans | 17 | 2024 | 42163 | 0.210 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 139 | 0.210 |
Why?
|
| Thrombin Time | 2 | 2020 | 2 | 0.200 |
Why?
|
| Partial Thromboplastin Time | 2 | 2020 | 9 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 255 | 0.190 |
Why?
|
| Factor XIIIa | 1 | 2022 | 1 | 0.190 |
Why?
|
| Ethacrynic Acid | 1 | 2022 | 2 | 0.190 |
Why?
|
| Antifibrinolytic Agents | 1 | 2022 | 4 | 0.190 |
Why?
|
| Models, Biological | 1 | 2006 | 711 | 0.190 |
Why?
|
| Factor IX | 1 | 2022 | 3 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 290 | 0.180 |
Why?
|
| Cell Proliferation | 6 | 2024 | 1420 | 0.180 |
Why?
|
| Computer Simulation | 4 | 2010 | 404 | 0.170 |
Why?
|
| Skin Neoplasms | 3 | 2011 | 175 | 0.170 |
Why?
|
| Drug Design | 2 | 2019 | 183 | 0.170 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2020 | 31 | 0.160 |
Why?
|
| Structure-Activity Relationship | 5 | 2024 | 491 | 0.160 |
Why?
|
| Hydroxamic Acids | 1 | 2019 | 34 | 0.160 |
Why?
|
| Factor VIIa | 1 | 2019 | 2 | 0.160 |
Why?
|
| Blood Coagulation Tests | 1 | 2019 | 5 | 0.160 |
Why?
|
| Factor Xa | 1 | 2019 | 4 | 0.160 |
Why?
|
| Thrombin | 1 | 2019 | 28 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 120 | 0.150 |
Why?
|
| Sulfonamides | 1 | 2019 | 88 | 0.150 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2017 | 6 | 0.140 |
Why?
|
| Mice | 9 | 2024 | 6490 | 0.120 |
Why?
|
| Skin Aging | 1 | 2016 | 10 | 0.120 |
Why?
|
| Sunscreening Agents | 1 | 2016 | 11 | 0.120 |
Why?
|
| Flavanones | 1 | 2016 | 12 | 0.120 |
Why?
|
| Hydrogen Bonding | 2 | 2007 | 143 | 0.120 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 2598 | 0.120 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2015 | 7 | 0.120 |
Why?
|
| Carbonic Anhydrase II | 1 | 2015 | 3 | 0.120 |
Why?
|
| Keratinocytes | 1 | 2016 | 67 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 100 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 118 | 0.120 |
Why?
|
| Dizocilpine Maleate | 1 | 2015 | 43 | 0.120 |
Why?
|
| Bile Acids and Salts | 1 | 2015 | 37 | 0.120 |
Why?
|
| Protein Structure, Secondary | 2 | 2006 | 185 | 0.110 |
Why?
|
| Piperidines | 1 | 2015 | 80 | 0.110 |
Why?
|
| Antigen-Presenting Cells | 1 | 2014 | 31 | 0.110 |
Why?
|
| Protein Conformation | 2 | 2006 | 420 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2015 | 133 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 73 | 0.110 |
Why?
|
| Bibenzyls | 1 | 2014 | 4 | 0.110 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 18 | 0.110 |
Why?
|
| Glycyrrhiza | 1 | 2013 | 1 | 0.110 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Thiazoles | 1 | 2014 | 76 | 0.110 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2013 | 31 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2014 | 2111 | 0.100 |
Why?
|
| Drug Discovery | 2 | 2024 | 106 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 727 | 0.100 |
Why?
|
| Pyridines | 1 | 2014 | 134 | 0.100 |
Why?
|
| Isoflavones | 1 | 2013 | 132 | 0.100 |
Why?
|
| Binding Sites | 4 | 2017 | 670 | 0.100 |
Why?
|
| Melanoma | 1 | 2013 | 109 | 0.090 |
Why?
|
| DNA | 1 | 2015 | 594 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 378 | 0.090 |
Why?
|
| Xanthenes | 1 | 2011 | 12 | 0.090 |
Why?
|
| Epidermis | 1 | 2011 | 22 | 0.090 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2011 | 22 | 0.090 |
Why?
|
| Administration, Oral | 2 | 2024 | 256 | 0.090 |
Why?
|
| Sunlight | 1 | 2011 | 48 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 103 | 0.090 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2011 | 14 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 98 | 0.090 |
Why?
|
| Flavonols | 1 | 2011 | 15 | 0.090 |
Why?
|
| Flavonoids | 1 | 2011 | 94 | 0.090 |
Why?
|
| Phosphatidylinositols | 1 | 2010 | 14 | 0.080 |
Why?
|
| Inositol | 1 | 2010 | 20 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 189 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 59 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2020 | 403 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 339 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2015 | 501 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2017 | 427 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1679 | 0.070 |
Why?
|
| Solubility | 1 | 2007 | 134 | 0.070 |
Why?
|
| Protein Subunits | 1 | 2007 | 93 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2007 | 157 | 0.070 |
Why?
|
| Brain | 1 | 2015 | 1452 | 0.070 |
Why?
|
| Solvents | 1 | 2007 | 109 | 0.070 |
Why?
|
| Protons | 1 | 2007 | 94 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2016 | 973 | 0.060 |
Why?
|
| Dimerization | 1 | 2006 | 115 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2013 | 884 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2006 | 221 | 0.060 |
Why?
|
| Protein Binding | 2 | 2020 | 1076 | 0.060 |
Why?
|
| Amino Acids | 1 | 2006 | 150 | 0.060 |
Why?
|
| Alanine | 1 | 2005 | 33 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 24 | 0.060 |
Why?
|
| Bacteriorhodopsins | 1 | 2005 | 33 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 94 | 0.060 |
Why?
|
| Lactams | 1 | 2024 | 9 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 300 | 0.060 |
Why?
|
| Aminopyridines | 1 | 2024 | 26 | 0.060 |
Why?
|
| Chick Embryo | 2 | 2014 | 77 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2024 | 75 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2024 | 93 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 2 | 2016 | 31 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2005 | 205 | 0.050 |
Why?
|
| Carbon | 1 | 2005 | 127 | 0.050 |
Why?
|
| Oxygen | 1 | 2005 | 217 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 1188 | 0.050 |
Why?
|
| Rats | 2 | 2024 | 3701 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2014 | 411 | 0.050 |
Why?
|
| Fibrin | 1 | 2022 | 10 | 0.050 |
Why?
|
| Patents as Topic | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2022 | 55 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2013 | 348 | 0.040 |
Why?
|
| Quercetin | 2 | 2011 | 46 | 0.040 |
Why?
|
| Enzyme Assays | 1 | 2020 | 13 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2011 | 165 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 1804 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 140 | 0.040 |
Why?
|
| Female | 5 | 2020 | 24018 | 0.030 |
Why?
|
| Biocatalysis | 1 | 2017 | 30 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2017 | 107 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2017 | 98 | 0.030 |
Why?
|
| Magnesium | 1 | 2017 | 93 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 205 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 114 | 0.030 |
Why?
|
| Microtubules | 1 | 2017 | 120 | 0.030 |
Why?
|
| Mice, Hairless | 1 | 2016 | 7 | 0.030 |
Why?
|
| Manganese | 1 | 2017 | 89 | 0.030 |
Why?
|
| Butadienes | 1 | 2016 | 29 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2016 | 26 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 20 | 0.030 |
Why?
|
| Luciferases | 1 | 2016 | 70 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 522 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2017 | 183 | 0.030 |
Why?
|
| Nitriles | 1 | 2016 | 78 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 148 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2016 | 82 | 0.030 |
Why?
|
| Tritium | 1 | 2015 | 51 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 151 | 0.030 |
Why?
|
| Chorioallantoic Membrane | 1 | 2014 | 11 | 0.030 |
Why?
|
| Piperazines | 1 | 2015 | 117 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 96 | 0.030 |
Why?
|
| Colchicine | 1 | 2014 | 15 | 0.030 |
Why?
|
| Laminin | 1 | 2014 | 58 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 49 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 72 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 102 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 62 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 147 | 0.030 |
Why?
|
| Glycyrrhizic Acid | 1 | 2013 | 4 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 80 | 0.030 |
Why?
|
| Tubulin | 1 | 2014 | 94 | 0.030 |
Why?
|
| Water | 1 | 2016 | 314 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 128 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 178 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 454 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 284 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 233 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 237 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 506 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2014 | 318 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 1416 | 0.020 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2011 | 8 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 686 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2011 | 41 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 184 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 173 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1066 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 106 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 640 | 0.020 |
Why?
|
| Static Electricity | 1 | 2010 | 85 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2010 | 166 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 217 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 387 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 928 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 1617 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 1058 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1541 | 0.010 |
Why?
|
| Male | 1 | 2013 | 22779 | 0.010 |
Why?
|